Comparison of Prices for Commonly Administered Drugs in Employer-Sponsored Insurance Relative to Medicare

This cross-sectional study compares unit prices and price growth in employer-sponsored insurance and Medicare over 2016 through 2020 for physician-administered drugs with the highest use and those with the highest spending.

Detalles Bibliográficos
Autores principales: Chang, Jessica Y., Sen, Aditi P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918879/
https://www.ncbi.nlm.nih.gov/pubmed/36763370
http://dx.doi.org/10.1001/jamahealthforum.2022.5422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918879/
https://www.ncbi.nlm.nih.gov/pubmed/36763370
http://dx.doi.org/10.1001/jamahealthforum.2022.5422

Ejemplares similares